Variant report
Variant | esv2760297 |
---|---|
Chromosome Location | chr13:76610840-76612996 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10507846 | chr13:76610840-76610841 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs142313045 | chr13:76610939-76610940 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs527482088 | chr13:76610954-76610955 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs183726727 | chr13:76610978-76610979 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs370213914 | chr13:76610995-76610996 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs561807376 | chr13:76611016-76611017 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs529306034 | chr13:76611036-76611037 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs189313183 | chr13:76611041-76611042 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs55775631 | chr13:76611100-76611101 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs539782134 | chr13:76611104-76611105 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs192670466 | chr13:76611129-76611130 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs577455148 | chr13:76611164-76611165 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs567071103 | chr13:76611209-76611210 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs534347571 | chr13:76611284-76611285 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs11149014 | chr13:76611307-76611308 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs573626400 | chr13:76611312-76611313 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs537923663 | chr13:76611327-76611328 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs555920862 | chr13:76611342-76611343 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs146169253 | chr13:76611359-76611360 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs368056837 | chr13:76611362-76611363 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs1461987 | chr13:76611432-76611433 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs559970066 | chr13:76611433-76611434 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs571920841 | chr13:76611464-76611465 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs542381438 | chr13:76611477-76611478 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs114394776 | chr13:76611509-76611510 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs17065521 | chr13:76611517-76611518 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs148262808 | chr13:76611570-76611571 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs562785911 | chr13:76611578-76611579 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs201122166 | chr13:76611587-76611588 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs35922215 | chr13:76611589-76611590 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs528025532 | chr13:76611601-76611602 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs141268619 | chr13:76611659-76611660 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs372286932 | chr13:76611683-76611684 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs150343323 | chr13:76611692-76611693 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs566610676 | chr13:76611712-76611713 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs552111248 | chr13:76611719-76611720 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs567133906 | chr13:76611755-76611756 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs534414091 | chr13:76611759-76611760 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs12428109 | chr13:76611779-76611780 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs9600631 | chr13:76611780-76611781 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs567832338 | chr13:76611814-76611815 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs537585035 | chr13:76611881-76611882 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs116052477 | chr13:76611883-76611884 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs560792419 | chr13:76611889-76611890 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs185123630 | chr13:76611906-76611907 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs79719946 | chr13:76611971-76611972 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs553667550 | chr13:76611979-76611980 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs571298426 | chr13:76612020-76612021 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs571984060 | chr13:76612050-76612051 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs138834832 | chr13:76612054-76612055 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 21858162 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Prostate cancer | 21965145 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
T-cell lymphomas | 22341440 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:76608000-76612000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
2 | chr13:76609600-76611000 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
3 | chr13:76609600-76613800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr13:76609800-76611000 | Enhancers | Muscle Satellite Cultured Cells | -- |
5 | chr13:76610400-76611400 | Enhancers | K562 | blood |
6 | chr13:76610400-76611600 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
7 | chr13:76610600-76611400 | Enhancers | Brain Anterior Caudate | brain |
8 | chr13:76610600-76611600 | Enhancers | Fetal Lung | lung |
9 | chr13:76610600-76611800 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
10 | chr13:76610600-76612400 | Enhancers | Fetal Thymus | thymus |
11 | chr13:76611200-76612000 | Enhancers | Thymus | Thymus |
12 | chr13:76611400-76613000 | Weak transcription | Brain Anterior Caudate | brain |
13 | chr13:76611600-76612200 | Weak transcription | Fetal Lung | lung |
14 | chr13:76611800-76613200 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |